Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study
2024 · British Journal of Cancer · 6 citations
https://doi.org/10.1038/s41416-023-02540-3
S
Shinya Urakawa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
610
Citations
10
h-index
10
i10-index
Shinya Urakawa is an academic researcher from Osaka Prefectural Medical Center. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Gastrointestinal Tumor Research and Treatment & Esophageal Cancer Research and Treatment. The author has an h-index of 10, co-authored 52 publications.
Papers by this author
worksThe potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy
2023 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-023-32645-x
Postoperative pain management using high-dose oral acetaminophen for enhanced recovery after colorectal cancer surgery
2024 · Surgery Today · 3 citations
https://doi.org/10.1007/s00595-024-02962-3
Surgical resection for solitary oligo-recurrence of the abdominal lymph node in the hepatoduodenal ligament after surgery for non-small-cell lung cancer - A case report
2025 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-7106828/v1
Surgical Resection for Solitary Oligo-Recurrence of the Abdominal Lymph Node in the Hepatoduodenal Ligament after Surgery for Non-Small-Cell Lung Cancer - a Case Report
2026 · SN Comprehensive Clinical Medicine · 0 citations
https://doi.org/10.1007/s42399-026-02276-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat